期刊文献+

多种动脉粥样硬化细胞因子与冠状动脉狭窄的相关性方程的建立及临床意义 被引量:4

The establishment of equation and clinical significant between variety of atherosclerosis cytokines and coronary artery stenosis
下载PDF
导出
摘要 目的探讨多种动脉粥样硬化细胞因子与冠状动脉粥样硬化性狭窄程度的相关性,以及可能的回归方程模型。方法将198例行冠状动脉造影的患者按造影结果 Gensini积分分为冠脉狭窄轻度组(0-12分,64人)、中度组(13-34分,54人)、重度组(>34分,32人)和冠脉正常对照组48人;采用单因素方差分析探讨冠脉狭窄组与对照组及不同狭窄组间临床基线资料、一般生化指标和细胞因子的差异,采用二元或多因素Logistic逐步回归方法探讨冠状动脉粥样硬化性狭窄与多种细胞因子的相关性,及建立回归方程模型。结果冠状动脉粥样硬化性狭窄组与对照组在性别、年龄、吸烟、高密度脂蛋白胆固醇、载脂蛋白A及细胞因子IGF-1、CTGF、Ox-LDL、TGF-β1、Lp-PLA2、sICAM-1、MMP-9、MPO、HSP-70比较有统计学意义;冠脉狭窄轻度组、中度组和重度组单因素分析显示:性别、吸烟、IGF-1、CTGF、Ox-LDL、TGF-β1、Lp-PLA2、sICAM-1和MMP-9组间差异有统计学意义;多因素Logistic回归分析建立冠状动脉狭窄程度评估模型:Gensini积分=12.806+0.05CTGF+0.199Lp-PLA2+0.139Ox-LDL+0.011TGF-β1(G=15.589,P=0.009)。结论冠状动脉粥样硬化性狭窄是一个多因素相互作用的结果,检测Lp-PLA2、Ox-LDL、TGF-β1和CTGF因子血清水平,通过回归方程模型可以更高效的诊断冠状动脉狭窄及评估冠脉狭窄严重程度。 Objective To investigate the establishment of equation and clinical significant between variety of atherosclerosis cytokines and coronary artery stenosisMethods One hundred and ninety eight patients were divided into coronary artery stenosis light group(0-12 points,64),median stenosis group(13-34 points,54),heavey stenosis group(〉34 points,32) and normal control group (n = 48)according to their Gensini score. The basic Clinical and laboratory data were analyzed by one-way ANOVA and multivariate logistic regression analysis. Results Male,age and smoking were more prevalent in the group with coronary stenosis compared to the control group. The levels of low density lipoprotein,apolipoproteinA,high density lipoprotein,lipoprotein alpha,IGF-1,CTGF,Ox-LDL,TGF-β1, Lp-PLA2, slCAM-1, MMP-9,MPO,HSP-70 were also different in the group of coronary stenosis than control. IGF-1,CTGF,Ox-LDL,TGF- β1 ,Lp-PLA2 ,slCAM-1 and MMP-9 were different in coronary artery stenosis subgroup according to AVONA. The equation model of 12. 806+0.05CTGF+0. 199Lp-PLAz +0. 139Ox-LDL+0. 011TGF-β1(G= 15. 589,P=0. 009) was established. Conclusion Variety of cytokines interaction lead to coronary artery stenosis,The serum levels of Lp-PLA2 ,ox-LDL,TGF-β1 and CTGF can be more elective diagnose of coronary stenosis and severe degree by equation model.
出处 《中国实验诊断学》 2016年第2期212-216,共5页 Chinese Journal of Laboratory Diagnosis
基金 贵州省省长基金临床应用课题专项研究[黔省专合字:(2012)117号]
关键词 冠状动脉狭窄 动脉粥样硬化细胞因子 方程模型 Coronary artery stenosis Atherosclerosis Cytokines Equation model
  • 相关文献

参考文献19

  • 1HUSheng Shou,KONG Ling Zhi,GAO Run Lin,ZHU Man Lu,WANG Wen,WANG Yong Jun,WU Zhao Su,CHEN Wei Wei,LIU Ming Bo,For the editorial board.Outline of the Report on Cardiovascular Disease in China,2010[J].Biomedical and Environmental Sciences,2012,25(3):251-256. 被引量:95
  • 2黄山,刘志琴,樊学军.心脏标志物临床与检验[M].北京:人民卫生出版社,2012:89-98.
  • 3Sullivan DR, Marwick TH, Freedman SB, et al. A new method of scoring coronary angiograms to reflect extent of coronary athero- sclerosis and improve correlation with major risk factors[J]. Am Heart J,1990,119(6) :1262.
  • 4Yang RF, Liu XY, Lin Z, et al. Correlation study on waist circum- ference triglyceride(WT) index and coronary artery scores in pa tients with coronary heart disease[J]. Eur Rev Med Pharmacol, 2015,19(1) :113.
  • 5Hopkins PN. Molecular biology of atheroselerosis[J]. Physiol Rev, 2013,93(3) : 1317.
  • 6Zhang R, Zhou SJ, Li CJ, et al. C reactive protein/oxidised low- density lipoprotein92-glycoprotein I complex promotes athero sclerosis in diabetic BALB/c mice via p38mitogen-activated pro rein kinase signal pathway[J]. Lipids in Health and Disease, 2013, 12(3) :42.
  • 7Chen C,Lei W,Chen WJ,et al. Serum TGF-131 and SMAD3 levels are closely associated with coronary artery disease[J]. BMC Car- diovascular Disorders, 2014,14 (1) : 18.
  • 8Charniot JC, Khani Bittar R, Albertini JP, et al. Interpretation of lipoprotein associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and tre- aments[J ]. International Journal of Cardiology, 2013, 168 ( 1 ) : 132.
  • 9Wu HD, Bai X, Chen DM, et al. Association of Genetic Polymor- phisms in Matrix Metalloproteinase 9 and Coronary Artery Disease in the Chinese Han Population:A Case - Control Study[J]. Genetic Testing and Molecular Biomarkers, 2013,17(9) : 707.
  • 10吴韦,姜醒华,黄谦,朱发友,叶君明.热休克蛋白70基因多态性在冠心病中的作用[J].临床心血管病杂志,2014,30(3):231-235. 被引量:6

二级参考文献27

  • 1Rosenson RS, Stafforini DM. Modulation of oxidative stress, inflammation, and atheroselerosis by lipoprotein-assoeiated phospholipase A2[J]. J Lipid Res, 2012, 53: 1767-1782.
  • 2Rosenson RS, Hurt-Camejo E. Phospholipase A2 enzymes and the risk of atheroselerosis[ J]. Eur Heart J, 2012, 33 : 2899-2909.
  • 3Ghanavatian S, Stein RA, Atar D, et al. The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction [J]. ClinLab, 2011, 57: 771-776.
  • 4Yuan SM, Shi YH, Wang JJ, et al. Elevated plasma D-dimer and hypersensitive C-reactive protein levels may indicate aortic disorders[ J]. Rev Bras Cir Cardiovasc, 2011, 26 : 573-581.
  • 5Lowe G. Can haemostatic factors predict atherothrombosis? [ J] Intern Emerg Med, 2011, 6: 497-501.
  • 6Catena C, Colussi G, Brosolo G, et al. A prothrombotic state is associated with early arterial damage in hypertensive patients [ J ]. J Atheroscler Thromb, 2012, 19 : 471-478.
  • 7Madarame H, Kurano M, Fukumura K, et al. Haemostatic and inflammatory responses to blood flow-restricted exercise in patients with ischaemic heart disease: a pilot study[ J]. Clin Physiol Funct hnaging, 2013, 33 : 11-17.
  • 8M~ckel M, Mtiller R, Vollert J, et al. Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-Ⅱ (NOBIS-Ⅱ ) [J]. Clin Res Cardiol, 2007, 96: 604-612.
  • 9Centers for Disease Control and Prevention (CDC). Prevalence of coronary heart disease-United States,2006-2010[J].Morbidity and Mortality Weekly Report,2011,(40):1377-1381.
  • 10Matheny M,McPheeters ML,Glasser A. Systematic review of cardiovascular disease risk assessment tools[Internet][M].Rockville (MD):Agency for Healtheare Research and Quality (US),2011.

共引文献205

同被引文献33

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部